Cite
HARVARD Citation
Inagaki, N. et al. (n.d.). Efficacy and safety of canagliflozin alone or as add‐on to other oral antihyperglycemic drugs in Japanese patients with type 2 diabetes: A 52‐week open‐label study. Journal of diabetes investigation. 6 (2), pp. 210-218. [Online].